(firstQuint)Study of FlutiForm Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma.

 This is a study involving a 2 week run-in phase followed by an 8 week double blind treatment phase.

 During the run-in phase, subjects receive Flixotide(R).

 In the treatment phase subjects will be randomised to one of the four treatment groups and will receive either high dose FlutiForm(R) and Foradil(R) plus Flixotide(R) placebo or low dose FlutiForm(R) plus Foradil(R) and Flixotide(R) placebo or Foradil(R) plus Flixotide(R) and FlutiForm(R) placebo or Flixotide(R) and FlutiForm(R) plus Foradil(R) placebo.

 Efficacy will be assessed by lung function tests, asthma symptoms, sleep disturbance due to asthma and rescue medication use.

 Safety will be assessed by adverse events, lab tests, ECGs and vital signs.

.

 Study of FlutiForm Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma@highlight

The study compares the efficacy and safety of FlutiForm(R) vs Flixotide(R) plus Foradil(R) in the treatment of severe persisent asthma in adult subjects.

